Acute gait disturbance associated with pamidronate infusion.

I. R. Reid, D. A. J. Mills, D. J. Wattie, Ototoxicity associated with intravenous bisphosphonate administration. Calcified Tissue International. ,vol. 56, pp. 584- 585 ,(1995) , 10.1007/BF00298594

H. Fleisch, R. Graham, G. Russell, M. D. Francis, Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivo Science. ,vol. 165, pp. 1262- 1264 ,(1969) , 10.1126/SCIENCE.165.3899.1262

F.J.M. Van Breukelen, OlavlM. Bijvoet, A.T. Van Oosterom, Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.). The Lancet. ,vol. 313, pp. 803- 805 ,(1979) , 10.1016/S0140-6736(79)91319-9

Gabriel N. Hortobagyi, Richard L. Theriault, Lester Porter, Douglas Blayney, Allan Lipton, Clive Sinoff, Helen Wheeler, Joseph F. Simeone, John Seaman, Robert D. Knight, Maika Heffernan, Dirk J. Reitsma, Ian Kennedy, Simon G. Allan, Kathleen Mellars, Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases The New England Journal of Medicine. ,vol. 335, pp. 1785- 1791 ,(1996) , 10.1056/NEJM199612123352401